Polyploidy is associated with enhanced S6K1–S6 signaling and improved tolerance to glucose starvation
Year: 2026
Type: article
Abstract: Polyploidy, a condition characterized by the presence of more than two complete sets of chromosomes, is associated with cancer, diabetes, and aging. The mechanistic target of rapamycin complex 1 (mTORC1) is a central regulator of cellular growth, protein synthesis, and metabolism, and its dysregulation contributes to the progression of these diseases. However, the relationship between mTORC1 signaling and polyploidy remains poorly understood. In this study, we investigated the role of mTORC1 signaling in the generation and maintenance of polyploid cells. Polyploidy was induced in HEK293T cells using cytochalasin B and ZM447439 and evaluated through flow cytometric analysis of DNA content (greater than 4 N), multinucleation, increased cell size, and asynchronous cell cycle. Both treatments promoted polyploidy and were associated with increased phosphorylation of S6K1 and S6, without significantly altering the phosphorylation of 4E-BP1. Notably, pharmacological inhibition of S6 signaling using Torin1 or rapamycin significantly reduced the accumulation of polyploid cells induced by cytochalasin B and ZM447439. Furthermore, under glucose starvation, polyploid cells exhibited improved survival, which was associated with reduced levels of apoptotic markers and increased MEK phosphorylation. Collectively, these findings indicate an association between polyploidy and increased phosphorylation of S6K1 and S6, while pharmacological inhibition of S6 signaling by Torin1 or rapamycin was associated with reduced polyploid cell accumulation. Furthermore, polyploid cells exhibited increased tolerance to glucose starvation, suggesting an association between the polyploid state and improved survival under metabolic stress. These findings suggest that the mTORC1–S6K1–S6 signaling axis may represent a potential therapeutic target in polyploidy-associated cancers.
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,700
Award: G6646936163
OpenAlex ID: W4399516915
